期刊文献+

非酒精性脂肪肝患者血清肿瘤坏死因子-α、脂联素水平与胰岛素抵抗的相关性 被引量:34

Pilot study correlating tumor necrosis factor-α,adiponectin and insulin resistance in patients with non-alcoholic fatty liver
下载PDF
导出
摘要 目的:探讨非酒精性脂肪肝(NAFLD)患者肿瘤坏死因子-α、脂联素水平与胰岛素抵抗等指标的相互关系.方法:120例NAFLD患者根据空腹血糖水平分为合并2型糖尿病(T2DM)者32例(DFL组),不伴T2DM者88例(FL组),所有NAFLD患者根据B超结果分为轻度、中度、重度3组.测定NAFLD患者及42例健康对照者的体质量指数(BMI)、腰臀比(WHR)、空腹血糖(FPG)、空腹胰岛素(FINS)、肿瘤坏死因子-α(TNF-α)、脂联素(APN)水平;采用稳态模式计算胰岛素抵抗指数(HOMA-IR)、胰岛素敏感性指数(ISI)、反应胰岛β细胞分泌功能的指标(HOMA-IS)等指标.结果:NAFLD患者的FINS,HOMA-IR均显著升高,ISI显著低于NC组(P<0.01);FPG,FINS,ISI,HOMA-IS是IR抵抗的主要相关因素;DFL组的FINS,HOMA-IR较FL组为高,ISI,HOMA-IS较FL组为低,均有显著性差异(P<0.01);NAFLD患者轻、中度两组间HOMA-IR无显著差异(P>0.05),而重度脂肪肝患者的HOMA-IR明显升高(P<0.01).NAFLD患者血清TNF-α显著升高,APN显著降低(P<0.01);APN与TNF-α,IR呈显著负相关,与ISI呈显著正相关;TNF-α是影响APN水平的重要因素;TNF-α与APN,ISI呈显著负相关,与FPG,FINS,IR呈显著正相关,ISI,APN是其主要的影响因素.结论:NAFLD患者普遍存在IR,合并2型糖尿病的NAFLD患者体内胰岛素抵抗现象更为明显;TNF-α与APN呈显著负相关,且均与IR密切相关.APN作为保护性因子而TNF-α作为损害性因子在NAFLD的发生、发展中起着重要作用. AIM: To measure serum tumor necrosis factor (TNF)-α and adiponectin (APN) levels in patients with non-alcoholic fatty liver disease (NAFLD), and to explore the relationship between this and insulin resistance. METHODS: Forty-two normal controls (NCs) and 120 patients with NAFLD were recruited, According to fasting plasma glucose (FPG), patients were divided into a group with NAFLD and type 2 diabetes (DFL; n = 32) and a simple NAFLD group (FL; n = 88). All patients with NAFLD were divided into mild (n = 59), moderate (n = 37) and severe (n = 24) categories, ac- cording to the results of B type ultrasound. Body mass index (BMI), waist-to-hip ratio (WHR), FPG, fasting insulin level in serum (FINS), serum APN and TNF-α were measured. Homeo- stasis model assessment (HOMA), insulin sensitive index (ISI) and insulin secretion (HOMA-IS) were applied to the status of insulin resistance (IR). Correlation analysis among these factors was analyzed. RESULTS: Compared with the NC group, FINS and HOMA-IR levels in the DFL and FL groups were significantly increased, and ISI was signifi- cantly decreased (all P 〈 0.01). Compared with the FL group, FINS and HOMA-IR levels in the DFL group were significantly increased, and ISI and HOMA-IS were significantly decreased (all P 〈 0.01). The difference in HOMA-IR level was not significantly different between the mild and moderate NAFLD groups (P 〉 0.05), which were both lower than the severe group (all P 〈 0.01). TNF-α level in the DFL and FL groups was significantly higher, while serum APN was significantly lower than that in the NC group (P 〈 0.01). Correlation analysis showed that APN was significantly negatively correlated with HOMA-IR and TNF-α, and positively correlated with ISI. TNF-α was significantly negatively correlated with APN and ISI, and positively correlated with FPG, FINS and IR. Multiple stepwise regression analysis showed that BMI, FPG, FINS and TNF-α were the main risk factors for IR. ISI and APN were the main risk factors for TNF-α. TNF-α was the main risk factor for APN. CONCLUSION: Insulin resistance is uniformly present in subjects with NAFLD and is more obvious in patients with type 2 diabetes. There is a significant negative correlation between APN and TNF-α, and both have close correlations with IR. APN has a protective role, while TNF-α causes impairment, and both have important roles in the pathogenesis and progression of NAFLD.
出处 《世界华人消化杂志》 CAS 北大核心 2007年第24期2613-2618,共6页 World Chinese Journal of Digestology
关键词 非酒精性脂肪肝 肿瘤坏死因子-Α 脂联素 胰岛素抵抗 Non-alcoholic fatty liver Tumor necro-sis factor-alpha Adiponectin Insulin resistance
  • 相关文献

参考文献6

二级参考文献257

  • 1王玉敏.B型超声"明亮肝”100例实验室肝功能检验分析[J].世界华人消化杂志,2000,8(z1). 被引量:2
  • 2胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 3Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1515
  • 4[1]Ludwig J,Viggiano TR,McGill DB,Oh BJ.Nonalcoholic steatohepatitis:Mayo Clinic experiences with a hitherto unnamed disease.Mayo Clin Proc 1980; 55:434-438
  • 5[2]Clark JM,Brancati FL,Diehl AM.Nonalcoholic fatty liver disease.Gastroenterology 2002; 122:1649-1657
  • 6[3]Ruhl CE,Everhart JE.Epidemiology of nonalcoholic fatty liver.Clin Liver Dis 2004; 8:501-519,vii
  • 7[4]Farrell GC,Larter CZ.Nonalcoholic fatty liver disease:from steatosis to cirrhosis.Hepatology 2006; 43:S99-S112
  • 8[5]Bellentani S,Tiribelli C,Saccoccio G,Sodde M,Fratti N,De Martin C,Cristianini G.Prevalence of chronic liver disease in the general population of northern Italy:the Dionysos Study.Hepatology 1994; 20:1442-1449
  • 9[6]Jimba S,Nakagami T,Takahashi M,Wakamatsu T,Hirota Y,Iwamoto Y,Wasada T.Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults.Diabet Med 2005; 22:1141-1145
  • 10[7]Brunt EM,Janney CG,Di Bisceglie AM,Neuschwander-Tetri BA,Bacon BR.Nonalcoholic steatohepatitis:a proposal for grading and staging the histological lesions.Am J Gastroenterol 1999; 94:2467-2474

共引文献3707

同被引文献407

引证文献34

二级引证文献235

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部